Ianalumab in Sjögren's syndrome: what can we learn from lupus trials? - authors' reply.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Abstract
No abstract availableCitation
Bowman SJ, Dorner T, Mariette X, Luo WL, Hueber W. Ianalumab in Sjögren's syndrome: what can we learn from lupus trials? - Authors' reply. Lancet. 2022 Sep 10;400(10355):808-809. doi: 10.1016/S0140-6736(22)01538-0Type
ArticleAdditional Links
http://www.sciencedirect.com/science/journal/01406736PMID
36088946Journal
The LancetPublisher
Elsevierae974a485f413a2113503eed53cd6c53
10.1016/S0140-6736(22)01538-0